POSTER SESSION II
Monday, March 19, 2012   —  1:00 PM - 4:30 PM
CC Exhibit Hall B3 & C


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


BONE & SOFT TISSUE PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
1 Complex Interphase Fluorescent In Situ Hybridization Patterns of EWSR1 Gene in Ewing Sarcoma Using Break Apart Probes (28)
H Chen, D McClain, SC Jhanwar, NP Agaram, MR Hameed - Memorial Sloan Kettering Cancer Center, New York, NY 		Add
2 Immunohistochemical Profile of 494 Genetically-Confirmed Ewing´s Sarcoma Cases (57)
A Llombart-Bosch, I Machado, M Alberghini, S Navarro - University of Valencia, Valencia, Spain; Orthopedic Institute Rizzoli, Bologna, Italy 		Add
3 Expression of ERG, an Ets Family Transcription Factor, Specifically Identifies ERG-Rearranged Ewing Sarcoma (81)
W-L Wang, NR Patel, M Caragea, D Lopez-Terrada, PCW Hogendoorn, JL Hornick, AJ Lazar - The University of Texas M.D. Anderson Cancer Center, Houston, TX; Texas Children´s Hospital/Baylor College of Medicine, Houston, TX; University of Western Ontario, Ontario, Canada; Leiden University Medical Center, Leiden, Netherlands; Brigham and Women´s Hospital, Boston, MA 		Add
4 Utility of a Monoclonal ERG/FLI1 Antibody for Immunohistochemical Discrimination of Ewing´s Family Tumors (76)
SA Tomlins, N Palanisamy, JC Brenner, JN Stall, DG Thomas, J Siddiqui, DR Lucas, AM Chinnaiyan, LP Kunju - University of Michigan Medical School, Ann Arbor, MI 		Add
5 Aberrant Calreticulin Expression Is Involved in the Dedifferentiation of Dedifferentiated Liposarcoma (44)
M Hisaoka, A Matsuyama - University of Occupational and Environmental Health, Kitakyushu, Japan 		Add
6 MDM2 Copy Numbers in Well Differentiated and Dedifferentiated Liposarcoma: Where Do We Draw the Line? (82)
P Ware, A Snow, M Pettenati, S Qasem - Wake Forest University Baptist Medical Center, Winston Salem 		Add
7 Well-Differentiated and Dedifferentiated Liposarcomas with Prominent Myxoid Stroma: Analysis of 55 Cases (72)
S Sioletic, CDM Fletcher, JL Hornick - Dana-Farber Cancer Institute, Boston, MA; Brigham and Women´s Hospital & Harvard Medical School, Boston, MA 		Add
8 KRAS Mutation in Lipomas, Atypical Lipomatous Tumors/ Well-Differentiated Liposarcomas (ALT) and Dedifferentiated Liposarcomas (DDLS) (63)
CY Ok, M Welch, K Tomaszewicz, L Hutchinson, EF Cosar - University of Massachusetts Memorial Medical Center, Worcester, MA 		Add
9 Dedifferentiated Liposarcoma of the Extremities: Relative Incidence Compared with Atypical Lipomatous Tumors of the Extremities, and Clinicopathologic Features Including Two Cases with Morphology of So-Called ´Inflammatory MFH´ (67)
S Reynolds, D Meredith, F Leech, R Quinn, B Schmit, T Bocklage - University of New Mexico SOM, Albuquerque, NM; UNM SOM, Albuquerque, NM 		Add
10 NY-ESO-1, a Cancer/Testis Antigen, Is Differentially Expressed in Myxoid/Round Cell Liposarcomas Compared to Other Liposarcoma Subtypes and Myxomatous Neoplasms (43)
J Hemminger, T Scharschmidt, J Mayerson, W Kraybill, OH Iwenofu - The Ohio State University Medical Center, Columbus, OH 		Add
11 Spindle Cell Liposarcoma, a Distinct Entity or Histologic Variant? Histologic and Molecular Analysis of 12 Cases (35)
AT Deyrup, F Chibon, L Guillou, P Lagarde, SW Weiss, J-M Coindre - USC-SOM, Greenville; Emory University, Atlanta; Institut Bergonie, Bordeaux, France; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland 		Add
12 Melanotic Schwannoma (MS): A ClinicoPathologic Study of 32 Cases (77)
J Torres-Mora, M Amin, AL Folpe - Mayo Clinic, Rochester, MN; William Beaumont Hospital, Detroit, MI 		Add
13 Rearrangement of DDIT3 (CHOP) in Perivascular Epithelioid Tumors (PEComas): A Novel Finding (70)
KE Schoedel, C Sherer, K Cieply, AL Folpe - University of Pittsburgh Medical Center, Pittsburgh, PA; Mayo Clinic, Rochester, MN 		Add
14 TFE3 Gene Rearrangement Status Is Heterogeneous in Alveolar Soft Part Sarcomas: A Study by Dual-Color Chromogenic In Situ Hybridization on Formalin-Fixed Paraffin-Embedded Samples (60)
T Motoi, A Yoshida, I Kato, T Hishima, K Tsuji, T Imamura, T Fukusato - Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan; The University of Tokyo, Tokyo, Japan; Teikyo University Hospital, Tokyo, Japan; Teikyo University, Tokyo, Japan 		Add
15 Muc-4 Expression and FUS Rearrangement in Sclerosing Epithelioid Fibrosarcomas: A Pathological Study of 20 Cases Further Supporting Relationship with Low Grade Fibromyxoid Sarcoma (66)
F Puls, K Thway, A Niblett, F Laenger, V Sumathi, C Fisher, CC Mangham, L-G Kindblom - Royal Orthopaedic Hospital, Birmingham, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Medical School Hannover, Hannover, Germany; Robert Jones & Agnes Hunt Orthopaedic Hospital, Oswestry, United Kingdom 		Add
16 Assessment of MUC4 Expression in Primary Bone Sarcomas (75)
R Tirabosco, F Berisha, D Halai, H Ye, A Swamy, MF Amary, A Flanagan - Royal National Orthopaedic Hospital, Stanmore - London, United Kingdom 		Add
17 Recurrent Amplification at 7q21.2 Targets CDK6 Gene in Primary Myxofibrosarcomas and Identifies CDK6 Overexpression as an Independent Adverse Prognosticator (78)
J-W Tsai, Y-C Kao, C-F Li, H-Y Huang - E-Da Hospital, Kaohsiung, Taiwan; Wan Fang Hospital, Taipei, Taiwan; Chi Mei Medical Center, Tainan, Taiwan; Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan 		Add
18 Characterization of Gene Amplification-Driven AMACR Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics (56)
C-F Li, H-Y Huang - Chi-Mei Medical Center, Tainan, Taiwan; Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan 		Add
19 Sampling Modality: Influence on Predicting Outcome in Adult Soft Tissue Sarcomas of the Extremities (51)
H Khoja, BC Dickson, JS Wunder, PC Ferguson, A Griffin, J Babwah, D Howarth, RA Kandel - Mount Sinai Hospital, Toronto, ON, Canada 		Add
20 Therapeutic Accuracy and Diagnostic Utility for Open Biopsy, Core Needle Biopsy and Fine-Needle Aspiration in a Series of 282 Biopsy Procedures: Comparison with Resection Diagnoses (69)
NA Sangle, LJ Layfield - University of Utah School of Medicine, Salt Lake City, UT 		Add
21 Angiomatoid Fibrous Histiocytoma: An Expansion of the Histologic Spectrum (20)
SL Bohman, BP Rubin, JR Goldblum, MR Tanas, SD Billings - Cleveland Clinic Foundation, Cleveland 		Add
22 MYH9-USP6 Fusion Transcript in Nodular Fasciitis: An Institutional Review (74)
DB Swanson, EB Cohen, L Ramyar, RA Kandel, BC Dickson - Mount Sinai Hospital, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada 		Add
23 Clinicopathologic Features of IgG4-Associated Retroperitoneal Fibrosis (55)
M Lew, M Carruthers, A Khosroshahi, R Hasserjian, JH Stone, GP Nielsen, V Deshpande - Massachusetts General Hospital, Boston, MA 		Add
24 CD47 Is a Therapeutic Antibody Target in Leiomyosarcoma (38)
B Edris, K Weiskopf, J Volkmer, S Willingham, A Volkmer, J Fletcher, A Beck, I Weissman, M van de Rijn - Stanford University School of Medicine, Stanford, CA; Harvard Medical School, Boston, MA 		Add
25 Abstract Withdrawn - Global MicroRNA Expression of Sarcomas. A Study of Formalin Fixed Paraffin Embedded Tissues Using NanoString MiRNA Assay PlatForm (71)
Add
26 Karyotyping Myofibroblastic/Fibroblastic Tumors: Continuing Usefulness of Standard Cytogenetic Methods in Detecting Novel Genetic Findings and Confirming the Histologic Diagnosis (40)
M Fitzpatrick, F Leech, D Meredith, R Quinn, T Bocklage - University of New Mexico School of Medicine, Albuquerque, NM; UNM SOM, Albuquerque, NM 		Add
27 Morphologic and Immunophenotypic Analysis of Desmoid- Type Fibromatosis Following Radiation Therapy (24)
JM Cates, JO Black, CC Wolfe, ET Shinohara, GE Holt, VL Keedy, KR Hande, KC Homlar, JL Halpern, HS Schwartz, CM Coffin - Vanderbilt University Medical Center, Nashville, TN; Vanderbilt Orthopaedic Institute, Nashville, TN 		Add
28 Transforming Growth Factor-β and Connective Tissue Growth Factor Are Mitogenic Output Mediators of Wnt/β-Catenin Signalling in Deep Fibromatosis (80)
S Varghese, W Kraybill, J Mayerson, T Scharschmidt, H Iwenofu - OSUMC, Columbus 		Add
29 Mesenteric and Superficial Fibromatosis Are Distinctly Different Tumors. A Proteomic Analysis Using Laser Microdissection and Mass Spectrophotometry (64)
A Papova-Butler, JP Shapiro, KB Green, MA Freitas, OH Iwenofu - OSUMC, Columbus, OH 		Add
30 Role of Macrophages and Tumor Angiogenesis in Desmoid- Type Fibromatosis (68)
S Romero, J Szafranska, E Cabrera, A Gonzalez, A Peiro, J Llauger, L Ortega, S Bague, B Canet, I Espinosa, J Prat - Hospital de la Santa Creu i Sant Pau. Institute of Biomedical Research (IIB Sant Pau). Autonomous University of Barcelona, Barcelona, Spain; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Hospital Clínico San Carlos, Madrid, Spain 		Add
31 Interphase Fluorescent In Situ Hybridization Patterns in Translocation Associated Sarcomas (59)
D McClain, H Chen, N Agaram, S Jhanwar, M Hameed - Montefiore Medical Center, Bronx, NY; Memorial Sloan Kettering Cancer Center, New York, NY 		Add
32 Diagnostic Value of aP2/FABP4 Expression in Soft Tissue Tumours (49)
TG Kashima, H Turley, A Dongre, F Pezzella, NA Athanaosu - Nuffield Orthopaedic Centre, University of Oxford, Oxford, United Kingdom; Oxford Radcliff Hospital, University of Oxford, Oxford, United Kingdom 		Add
33 Metastatic Solitary Fibrous Tumor/Hemangiopericytoma Overexpresses Multiple Growth Factors (34)
EG Demicco, D Araujo, J Trent, AJ Lazar, W-L Wang - The University of Texas M. D. Anderson Cancer Center, Houston, TX 		Add
34 In Vitro Assessment of Sarcoma Cell Lines Sensitivity to mTOR Inhibitors and Correlation with Genomic Data Evidence Limited Therapeutic Potential (53)
F Le Loarer, G Perot, P Lagarde, AL Peille, JM Coindre, F Chibon - Institut Bergonie, Bordeaux, France 		Add
35 FBXW7 Mutations in a Subset of Embryonal Rhabdomyosarcoma (47)
E Jacobson-Dunlop, A Mansoor, C Corless, M Heinrich, C Beadling - Oregon Health and Science University, Portland, OR 		Add
36 Intimal Sarcoma Represents the Most Common Primary Cardiac Sarcoma: A French National Retrospective Clinicopathologic and Molecular Study of 84 Cardiac Sarcomas. Implications for Diagnosis and Treatment (62)
A Neuville, F Collin, P Bruneval, M Parrens, F Thivolet- Bejui, A Gomez-Brouchet, P Terrier, F Piard, V Thomas De Montpreville, P Lagarde, F Chibon, J-M Coindre - Institut Bergonié, Bordeaux, France; Centre Georges-François Leclerc, Dijon, France; CHU-Hôpital Européen Georges Pompidou, Paris, France; CHU-Hôpital Haut-Levêque, Bordeaux, France; CHU-Groupement Hospitalier Est, Lyon, France; CHU Rangueil, Toulouse, France; Institut Gustave Roussy, Paris, France; CHU de Dijon, Dijon, France; Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France 		Add
37 Advantages of a National Pathological Network for a Systematic Second Review in Sarcomas: Experience of a One- Year Activity in France (30)
JM Coindre, D Ranchere-Vince, P Terrier, JF Emile, B Chetaille, S Le Guellec, YM Robin, F Collin, AV Decouvelaere, A Neuville - Bergonié, Bordeaux, France; Centre Léon Bérard, Lyon, France; Institut Gustave Roussy, Villejuif, France; APHP, Paris, France; Institut Paoli Calmettes, Marseille, France; Institut Claudius Regaud, Toulouse, France; Centre Oscar Lambret, Lille, France; Centre Georges-François Leclerc, Dijon, France 		Add
38 Pathologic Response to Neoadjuvant Radiotherapy (NRT) as Potential Prognostic Factors in Soft Tissue Sarcomas (STS) (26)
JC Chang, M Bedi, DL Stockman, D Wang, EV Zambrano - Medical College of Wisconsin, Milwaukee, WI 		Add
39 Skeletal Metastases: An Analysis of Patients with Unknown Primary Site (79)
C Uram-Tuculescu, G Domson, WC Foster, E Dragoescu - Virginia Commonwealth University, Richmond, VA 		Add